Project Description
San Clemente, CA
Metagenics, Inc
Fund
Fund
I
Realized
Exited
2009
Healthcare
Healthcare Services
Metagenics, Inc
Metagenics, Inc. is a leading provider of medical foods and nutraceuticals to medical practitioners worldwide. Founded in 1983 and headquarterd in San Clemente, California, Metagenics’ goal is to help people achieve their genetic potential through nutrition.
The company currently sells over 400 all-natural, research-based products formulated to treat the chronic health problems associated with cardiovascular disease, inflammation, gastrointestinal disease and endocrine disorders. With over 400 employees worldwide, including a team of over 30 scientific specialists and clinicians, the company has built a reputation for providing products that meet the highest standards of safety, efficacy, and quality. Metagenics complies with the rigorous standards for Good Manufacturing Practices and is certified by the National Nutritional Foods Association, NSF International and the Therapeutic Goods Administration of Australia.
Metagenics, Inc
Metagenics has built a reputation for providing products that meet the highest standards of safety, efficacy, and quality. The company complies with the rigorous standards for Good Manufacturing Practices and is certified by the National Nutritional Foods Association (“NNFA”), NSF International (“NSF”), and the Therapeutic Goods Administration of Australia (“TGA”).
With over 500 employees worldwide, including a team of over 30 scientists and clinicians, Metagenics is helping to shape the future of the nutraceutical industry and integrative medicine.
Bison Team
Metagenics, Inc
“We are very excited to be forming a partnership with Metagenics. We believe that the company’s superior management team and pioneering research and development efforts will allow Metagenics to retain its leading position in this high growth segment of the dietary supplement market. Our capital, which enables the company to consummate two acquisitions, will help Metagenics continue its impressive growth trajectory.”
– Ping Chu, partner at Bison Capital
